- IBM shares rose 2.4% to $249.09, trading as high as $251.37 against a prior close of $243.29, on mid-day volume of 6,452,899 shares.
- IBM subsidiary Anderon finalized a $1 billion CHIPS Act award from the US Department of Commerce to accelerate R&D for a US-based pure-play quantum foundry, supporting quantum-wafer technology, manufacturing capacity, and broader access to IBM's quantum platform.
- IBM's AI technology is in production at a Turkish credit bureau handling about 23 million transactions daily, evidence that IBM AI products are running in high-volume enterprise workloads even though the contract value was not disclosed.
- The open-source NASA-IBM Lunar Foundation Model release reframes IBM as a defensive growth technology investment transitioning into a software and AI-led enterprise platform company.
- Analysts carry an average IBM price target of $265.16 to $265.90, above the current trading level, with 17 Buy ratings, 10 Holds, and 1 Sell.
- Overhangs: an IBM executive sold 25,000 shares, and coverage linking IBM to consulting-sector discrimination settlements creates reputational and legal risk without a specified financial impact.
引述
“IBM subsidiary Anderon finalized a $1 billion CHIPS Act award from the U.S. Department of Commerce to accelerate research and development for a U.S.-based pure-play quantum foundry.”
“IBM's AI technology is being deployed by a Turkish credit bureau to process approximately 23 million transactions daily.”
“defensive growth technology investment transitioning into a software and AI-led enterprise platform company”